Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition

Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition

ABSTRACTThis study aimed to develop a computed tomography (CT)-based radiomics model capable of precisely predicting hyperprogression and pseudoprogression (PP) in patients with non-small cell lung cancer (NSCLC) treated with immunotherapy. We retrospectively analyzed 105 patients with NSCLC, from t...

Full description

Bibliographic Details
Main Authors: Yikun Li, Peiliang Wang, Junhao Xu, Xiaonan Shi, Tianwen Yin, Feifei Teng
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:OncoImmunology
Subjects:
Computed tomography
hyperprogression
immunotherapy
non-small cell lung cancer
pseudoprogression
radiomics
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2024.2312628

Internet

https://www.tandfonline.com/doi/10.1080/2162402X.2024.2312628

Similar Items